Head to head
Mochi Health vs Willow
Both are real, operating US telehealth companies. What separates them is what they supply, what they charge for it, and what regulators have published about each — all of it below, linked to the primary documents.
- Mochi Health
- Both
$79/mo - Willow
- Compounded
$299/mo - Mochi Health on file
- 3
- Willow on file
- 3
Side by side
What each one publishes about itself
Every figure here is the provider’s own advertised number, not an estimate. A dash means the company does not publish it.
| Mochi Health | Willow | |
|---|---|---|
| Supplies | Compounded and branded | Compounded only |
| Advertised from | $79/mo | $299/mo |
| First month | $39 | — |
| Medication in the price | Billed separately | Included |
| Insurance | — | Cash pay |
| Intake | Async | Async |
| On the record | 3 actions | 3 actions |
The difference that actually matters
Mochi Health: Supplies both compounded medication and FDA-approved branded drugs, usually at very different prices. Check which one a quoted price refers to. Willow: Supplies compounded semaglutide or tirzepatide — medication prepared by a compounding pharmacy, not an FDA-approved product. Cheaper, legal, and the category the FDA has been issuing warning letters about.
What is on Mochi Health’s record
2025-04
Eli Lilly sued Mochi Health Corp. in the Northern District of California on 23 April 2025 (No. 3:25-cv-03534) over compounded tirzepatide combined with additives including niacinamide, pyridoxine and glycine. In October 2025 the court granted Mochi's motion to dismiss with leave to amend, holding Lilly had not established standing on reputational harm alone.
2025-08
Novo Nordisk sued Mochi Health Corp. and its affiliated medical practices in the Northern District of California on 4 August 2025 (No. 5:25-cv-06563), alleging false advertising and unlawful mass compounding of semaglutide, including converting standard doses to non-standard ones and adding vitamin B12; allegations unproven.
2025-03
The Washington State Pharmacy Quality Assurance Commission issued a Limited Stop Service order on 13 March 2025 against Aequita Pharmacy LLC of Kirkland, Washington — reported to compound for Mochi Health — barring it from compounding or dispensing compounded products in the state, citing untrained and unqualified staff performing sterile compounding, inadequate supervision, and failure to follow sterile compounding procedures.
What is on Willow’s record
2025-12
The National Advertising Division, on a challenge by Novo Nordisk, recommended on 4 December 2025 that Willow Health Services discontinue or modify health claims for its compounded semaglutide products. Willow declined to provide a compliance statement, and NAD referred the matter to regulatory authorities and to the platforms carrying the advertising.
2026-07
Reopened NAD matter closed after Willow Health Services voluntarily discontinued claims that its compounded semaglutide was proven to support weight loss, delivered results comparable to FDA-approved semaglutide, and produced effective weight loss without diet or exercise.
2026-02
Eli Lilly sued Willow Health Services, Inc. in the Central District of California on 23 April 2025 (No. 2:25-cv-03570) over compounded tirzepatide. The case was dismissed with prejudice on 3 February 2026 for failure to establish Lanham Act standing — the court held the prescribing physician, not Willow's advertising, was the proximate cause of any lost sales — with no ruling on whether the marketing was misleading. Lilly has appealed to the Ninth Circuit (No. 26-1317).
Go direct
Both companies, and what we earn from each
We do not recommend one over the other. Where a link pays us, it says so here and on the provider’s own page.
Mochi Health
Compounded and branded, from $79 a month. 3 actions on record, each linked on its page. The link below earns us nothing.
Willow
Compounded only, from $299 a month. 3 actions on record, each linked on its page. The link below is an affiliate link and pays us a commission; it changed nothing above.
Straight answers
Mochi Health vs Willow, in short
- Is Mochi Health or Willow cheaper?
- Mochi Health advertises the lower starting price — $79 a month against $299, roughly 3.8× the difference. Whether that is the cheaper purchase depends on what each figure covers: Mochi Health bills medication separately, and Willow includes it.
- What is the difference between Mochi Health and Willow?
- Mochi Health: both compounded and FDA-approved medication. Willow: compounded medication only. One of the two sells both categories, so its advertised headline price almost certainly refers to the compounded option.
- Which one has more regulatory actions on record?
- They are level, at 3 actions each. The actions themselves are not equivalent — read them on each provider's page.
Other comparisons: Found vs Mochi Health · Henry Meds vs Willow · Henry Meds vs Mochi Health · Mochi Health vs Zealthy · Mochi Health vs Ivím Health · Eden vs Willow